Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Verified
RNA Interference (RNAi, si/shRNA) » Genetic Resources Core Facility, Johns Hopkins University, School of Medicine
The GRCF offers custom & pre-designed siRNAs, shRNAs, miRNA mimics and other RNAi products Custom siRNA Custom siRNAs can be used in cell culture experiments to silence genes. Horizon Discovery, IDT, MilliporeSigma and ThermoFisher all offer a variety of custom design options, modifications and purification possibilities. Each company has their own set of design tools that are […]
by Genetic Resources Core Facility (GRCF)
Baltimore, United States
10001+ Employees
1989
Our goal is to provide the research community with access to ‘next generation’ sequencing platforms as well as foundational sequencing alternatives. The GRCF is a JHU service center producing a number of products and services to aid researchers performing studies in cell biology, molecular biology and genetics. We are also happy to write letters of support for grant applications, demonstrating to reviewers that the resources for your study are available at the university. The GRCF works to stay at the leading edge of technology, by providing sophisticated tools and equipment oftentimes not available in the individual research lab. The GRCF offers regular webinars and seminars to the Johns Hopkins Community. Annually, the GRCF Symposium combines guest research speakers and vendors offering the latest technology, for a unique progressive research experience. We are deeply appreciative of the dedication and commitment of the GRCF team to our Hopkins community.”. Provides one-stop shopping for more than 400,000 products from 17 of the leading life science companies.
+
Featured
RNA Interference Products
... RNA Interference (RNAi, si/shRNA) » Genetic Resources Core Facility, Johns Hopkins University, School of ...
Muttenz, Switzerland
1-10 Employees
1999
We are a dynamic, highly motivated team specializing in the distribution of reagents and laboratory equipment for life science research and clinical diagnostics, particularly in the fields of cell and molecular biology. We are thoroughly committed to our employees, who work for our company. Our cornerstones are professional and competent support by the LabForce Team in the fields of life science research and clinical diagnostics. Our strength is the entirety of quality, mentality and personality of all customers, suppliers and employees. Our range of products and service is designed to suit with the targets and needs of our customers. These are basically high-quality products, excellent service, assistance and consulting, and also the pleasure to always be of help to our customers. The success and performances of LabForce AG are constantly improved by further training and suggestions for improvement by all members of the staff and advice of external specialists. AccuPAGE gels for all your MINI-PAGE systemsHigh quality gelsPrice from CHF 8.70 per gelcontact LabForce for more info.
+
Featured
RNA Interference
... RNA Interference | LabForce ...
Allentown, United States
1001-5000 Employees
1919
We are united through our values and our common purpose which is to help our clients succeed and ensure their patients who have medical needs can live a better life. We are committed to limiting the impact we have on the environment and helping to protect our planet for the generations to come. We deliver what our clients need and amplify the value we bring through collaborative relationships across their supply chain. We deliver innovative primary and secondary packaging solutions from our GMP sites in the US, EU, and UK. Sharp is a leader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing, with a heritage spanning more than 70 years. Together, our 2,000+ strong team leverage the capabilities in state-of-the-art GMP facilities in the US, UK, Belgium and the Netherlands. We believe it is a privilege to work in the life science industry. It drives us to provide the safest and most advanced packaging solutions that guarantee the quality, traceability and compliance of our customers’ products.
+
Featured
Hamont-Achel Archives | Sharp Services
... Alnylam Pharmaceuticals partners with Sharp on packaging RNA interference (RNAi) therapeutics for ...
Hyderabad, India
251-500 Employees
2003
We provide a wide range of services from Gene synthesis to Protein expression. We have built a formidable customer base in India and understand the needs of our customers. We also offer consultancy services to firms and institutions requiring assistance in the fields of biotechnology, molecular biology, proteomics. To be the leading service provider in all areas of industrial and academic biotechnology in India with a knowledge-based approach and personalized customer service. We undertake custom antibody production for polyclonal and monoclonal antibodies. We distribute and market products for Life sciences research.
+
Featured
Welcome to Biotech Desk Pvt. Ltd.
... RNA interference ...
Lexington, United States
101-250 Employees
2007
At Dicerna, we use RNA interference, or RNAi, to create medicines that silence or turn off the genes that cause or contribute to disease. Using our GalXC™ and GalXC-Plus™ technologies, we aim to develop safe, effective, specific and convenient RNAi therapies – in-house and with our partners – for both rare and common diseases. Our proprietary GalXC platform has the potential to open a world of possibilities for creating targeted RNAi therapies. Our GalXC platform is comprised of our liver-targeted GalXC technology and our GalXC-Plus technology for tissues outside the liver. Each utilizes a set of proprietary double-stranded RNA structures capable of inducing RNAi and associated chemical modifications and additions to these structures to enhance their pharmaceutical properties.
+
Featured
Information About Dicerna Pharmaceuticals | Dicerna Pharmaceuticals
... Dicerna Pharmaceuticals is a biopharmaceutical company using RNA interference, or RNAi, to create medicines that silence the genes that cause or contribute to rare or common diseases. ...
Tzafria, Israel
11-50 Employees
1952
At Eisenberg, we work closely with our global suppliers to deliver best-in-class solutions to our customers. Through our customer-centric approach and by building long-term relationships with our clients, we can deliver tailored solutions for the rapidly evolving needs of the modern market.
+
Featured
SiTools - Eisenberg Bros LTD
... Leading provider of RNA interference (RNAi) and other solutions to silence gene expression. ...
Orlando, United States
1-10 Employees
1994
We provide technical service in the design of novel probes and synthesize numerous combinations of dyes, quenchers, RNA, phosphorothioate, 2′-O-methyl and chimeric probes. We believe that investigators who value time and have no room for an experiment to fail due to oligo quality should consider Gene Link. Gene Link offers synthesis of various forms of molecular primers and probes. Gene Link offers enhanced PCR Amplification & Analysis that includes meticulous proofing of each automated base call. Gene Link is committed to provide superior quality products and custom services. Gene Link is the leader in triple repeat disorder genotyping using non-radioactive based methods. Gene Link’s expertise in long oligo synthesis makes it the natural first choice for all your needs for synthetic genes & DNA Fragment Construction. Tested for more than a decade and offered to you as convenience reagents.
+
Featured
oligos - custom oligo synthesis, oligonucleotides, custom rna synthesis, gel page rpc hplc reverse cartridge purification,modifications,rnai sirna,probes from Gene Link
... RNA Interference ...
Pune, India
51-100 Employees
2014
Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation. Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ offers (B2B) market research reports such as syndicated market research reports, custom….
+
Featured
RNA Analysis Market Report
... , Instruments, Software and Services), Technology (Real Time-PCR, Microarrays, Sequencing and RNA Interference), Application (Epigenetics, Infectious Diseases and Pathogenesis, Alternative RNA Splicing, RNA Structure and Molecular Dynamics, Development and Delivery of RNA Therapeutics, ...
Ireland
1-10 Employees
2009
MyBio is the exclusive supplier of many of the world’s leading bioscience products. MyBio give you easy access to Proteintech’s extensive range of high quality and competitively priced antibodies, cytokines, and other essential research products. A trusted provider of bespoke commercial solutions to partners and customers. Delivering innovative leading edge technologies into the Irish market to enable new discoveries in life sciences. It has the largest proprietary portfolio of self-manufactured antibodies, covering 2/3 of the human proteome. With over 200,000 products cited and confirmed specificity, Proteintech offers antibodies and immunoassays across a wide range of research areas. Proteintech supply over 15,000 products against 13,000 different proteins. This selection currently covers 2/3 of the human proteome and is self manufactured and validated for reproducibility, creating unparalleled quality and uninterrupted supply.
+
Featured
psiCHECK-2 Vector – MyBio Ireland
... They are used for optimizing RNA interference assays. ...
San Diego, United States
1-10 Employees
2012
Xcess Biosciences Inc (XcessBio or Xbio) was founded in 2008 by scientists from academia and BioPharma industry with strong expertise in chemistry and biology. We are dedicated to develop high-quality products and deliver the best services for our customers. We diligently develop high quality products and strive to earn your satisfaction. If you know of any technology, product, or service development opportunities in the fields related, we would be very interested in hearing from you. SD70 is a potent, selective and cell-permeable inhibitor of histone demethylase JMJD2 (KDM4C), identified by phenotypic screening for inhibitors of ligand and genotoxic stress-induced translocations in prostate cancer cells.
+
Featured
BQU57 --- GTPase Ral Inhibitor – Xcess Biosciences
... and RhoA and inhibited tumour xenograft growth to a similar extent to the depletion of Ral using RNA interference. It inhibited the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of ...
RNA interference (RNAi) is a process that occurs in living cells where the expression of certain genes is suppressed or inhibited by the introduction of small interfering RNA (siRNA) molecules. RNAi acts as a natural defense mechanism against foreign genetic material, such as viruses, and can also be used to regulate gene expression. The siRNA molecules bind to and degrade mRNA, preventing it from being translated into a protein. This process of gene silencing is widely used in the study of gene function and has the potential to be used in the development of new therapeutic treatments.